Pancreatic Cancer Research

ResearcherUniversity of ArizonaNo recent work listed

Abhishek D. Parmar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3750-3448; OpenAlex author ID A5034832308. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper

Papers 5

  1. Trends in Receipt and Timing of Multimodality Therapy in Early-Stage Pancreatic Cancer. Co-author DOI 10.1007/s11605-015-2952-7↗
  2. Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates? First author DOI 10.1007/s11605-014-2620-3↗
  3. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2014.03.001↗
  4. Evaluating comparative effectiveness with observational data: endoscopic ultrasound and survival in pancreatic cancer. Co-author DOI 10.1002/cncr.28295↗
  5. Current trends in preoperative biliary stenting in patients with pancreatic cancer. First author DOI 10.1016/j.surg.2013.03.016↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Taylor Sohn Riall · 5 shared papers, 2013–2016 · strength 0.26
  2. Kristin M. Sheffield · 3 shared papers, 2013–2014 · strength 0.13
  3. Ahmedin Jemal · 1 shared paper, 2016 · strength 0.07
  4. Francesca M. Dimou · 1 shared paper, 2016 · strength 0.07
  5. Matthew H. G. Katz · 1 shared paper, 2015 · strength 0.06
  6. Amanda Beth Cooper · 1 shared paper, 2015 · strength 0.06
  7. Henry Anthony Pitt · 1 shared paper, 2015 · strength 0.06
  8. Lindsay J. Jinkins · 1 shared paper, 2013 · strength 0.04
  9. Kimberly M. Brown · 1 shared paper, 2013 · strength 0.04
  10. James S. Goodwin · 1 shared paper, 2013 · strength 0.04
  11. Yong‐Fang Kuo · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.